Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1–6 Hepatitis C Virus Infections and Compensated Liver Disease

BACKGROUND: Untreated, chronic hepatitis C virus (HCV) infection may lead to progressive liver damage, which can be mitigated by successful treatment. This integrated analysis reports the safety, efficacy, and pharmacokinetics (PK) of the ribavirin-free, direct-acting, antiviral, fixed-dose combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gane, Edward, Poordad, Fred, Zadeikis, Neddie, Valdes, Joaquin, Lin, Chih-Wei, Liu, Wei, Asatryan, Armen, Wang, Stanley, Stedman, Catherine, Greenbloom, Susan, Nguyen, Tuan, Elkhashab, Magdy, Wörns, Marcus-Alexander, Tran, Albert, Mulkay, Jean-Pierre, Setze, Carolyn, Yu, Yao, Pilot-Matias, Tami, Porcalla, Ariel, Mensa, Federico J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821220/
https://www.ncbi.nlm.nih.gov/pubmed/30923816
http://dx.doi.org/10.1093/cid/ciz022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821220/
https://www.ncbi.nlm.nih.gov/pubmed/30923816
http://dx.doi.org/10.1093/cid/ciz022

Ejemplares similares